Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak expiratory flow values before and after therapy

J Investig Allergol Clin Immunol. 2010;20(5):451-2.

Authors

G Kourtis¹, A S Rucco, F Loconte, M F Caiaffa, L Macchia

Affiliation

¹ Department of Allergology and Clinical Immunology, University of Bari, Bari, Italy.

PMID: 20945619

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal / administration & dosage*
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal, Humanized
Asthma / diagnosis
Asthma / drug therapy*
Asthma / physiopathology
Cough
Female
Humans
Male
Middle Aged
Monitoring, Physiologic / instrumentation
Monitoring, Physiologic / methods
Omalizumab
Peak Expiratory Flow Rate*
Recovery of Function
Respiratory Sounds
Retrospective Studies

Substances

Antibodies, Anti-Idiotypic
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Omalizumab